Loading…
Reported covered position: ; ;
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
340B Transparency Act
Client: THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) · Firm: CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
HR 3290 -- to amend the public health services act regarding the 340B drug discount program. (opposition)
340B Transparency Act
Client: THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) · Firm: CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
HR 3290 -- to amend the public health services act regarding the 340B drug discount program. (opposition)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HARTWELL CAPITOL CONSULTING *ON BEHALF OF DRAI HEALTH) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · second_quarter · 2A
Artificial intelligence system for VA healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
HARTWELL CAPITOL CONSULTING *ON BEHALF OF DRAI HEALTH) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · second_quarter · 2A
Source: Senate LDA
| 2026 |
| B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF MCCORD HEALTH, INC.) | 5 | 2024–2025 |
| Sensus Healthcare, Inc. | 5 | 2025 |
| B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF COVISUS, INC.) | 4 | 2024 |
| THE LIVINGSTON GROUP (ON BEHALF OF RAVENSAFE) | 3 | 2021 |
| THE LIVINGSTON GROUP, LLC (ON BEHALF OF NJOY LLC) | 3 | 2018–2019 |
| THE LIVINGSTON GROUP (ON BEHALF OF AYASS BIOSCIENCES) | 2 | 2021 |
340B Transparency Act
Client: THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) · Firm: CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
HR 3290 -- to amend the public health services act regarding the 340B drug discount program. (opposition)
Artificial intelligence system for VA healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
HARTWELL CAPITOL CONSULTING *ON BEHALF OF DRAI HEALTH) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · second_quarter · Q2
Artificial intelligence system for VA healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · second_quarter · Q2
graduate education and training for clinical pharmacists
recognition and coverage for clinical pharmacy services; graduate level pharmacy training and education
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HARTWELL CAPITOL CONSULTING *ON BEHALF OF DRAI HEALTH) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · first_quarter · RA
Artificial Intelligence systems for health services in VA Health System and Medicare
Artificial Intelligence systems for health services in VA Health System and Medicare
HARTWELL CAPITOL CONSULTING *ON BEHALF OF DRAI HEALTH) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · first_quarter · Q1
Artificial intelligence system for VA healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
HARTWELL CAPITOL CONSULTING *ON BEHALF OF DRAI HEALTH) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · first_quarter · RR
Artificial intelligence medical systems in VA and Medicare
Artificial intelligence medical systems in VA and Medicare
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2026 · first_quarter · Q1
recognition and coverage for clinical pharmacy services; graduate level pharmacy training and education
graduate education and training for clinical pharmacists
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSUS HEALTHCARE, INC. via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · fourth_quarter · 4T
medicare fee schedule and coverage for skin cancer treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSUS HEALTHCARE, INC. via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · fourth_quarter · Q4
Coverage and reimbursement for skin cancer treatments
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · fourth_quarter · Q4
recognition and coverage for clinical pharmacy services; graduate level pharmacy training and education
graduate education and training for clinical pharmacists
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSUS HEALTHCARE, INC. via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · third_quarter · Q3
Coverage and reimbursement for skin cancer treatments
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · third_quarter · Q3
recognition and coverage for clinical pharmacy services; graduate level pharmacy training and education
graduate education and training for clinical pharmacists
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · second_quarter · Q2
recognition and coverage for clinical pharmacy services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSUS HEALTHCARE, INC. via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · second_quarter · Q2
Coverage and reimbursement for skin cancer treatments
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSUS HEALTHCARE, INC. via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · second_quarter · RR
skin cancer treatment and prevention issues
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF MCCORD HEALTH, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · first_quarter · 1T
Medicare coverage for wound treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2025 · first_quarter · Q1
recognition and coverage for clinical pharmacy services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF COVISUS, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · fourth_quarter · 4T
FDA recognition for technology to assist with medical device tracking and recalls
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF MCCORD HEALTH, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · fourth_quarter · Q4
Medicare coverage and recognition of innovative wound care treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · fourth_quarter · Q4
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF MCCORD HEALTH, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · second_quarter · Q2
Medicare coverage and recognition of innovative wound care treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF MCCORD HEALTH, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · third_quarter · Q3
Medicare coverage and recognition of innovative wound care treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF COVISUS, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · third_quarter · Q3
FDA recognition for technology to assist with medical device tracking and recalls
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF COVISUS, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · second_quarter · Q2
FDA recognition for technology to assist with medical device tracking and recalls
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF MCCORD HEALTH, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · second_quarter · RR
Coverage and recognition for innovative wound care treatments.
B. GLACKIN & ASSOCIATES, LLC (ON BEHALF OF COVISUS, INC.) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · second_quarter · RR
Educate Congress and FDA on technology to advance medical product tracking and recalls.
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · third_quarter · Q3
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · second_quarter · Q2
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · first_quarter · 1T
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · first_quarter · 1T
HR 3290 -- to amend the public health services act regarding the 340B drug discount program. (opposition)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2024 · first_quarter · Q1
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · fourth_quarter · Q4
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · fourth_quarter · Q4
HR 3290 -- to amend the public health services act regarding the 340B drug discount program. (opposition)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · fourth_quarter · Q4
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · third_quarter · Q3
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · third_quarter · Q3
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · third_quarter · Q3
HR 3290 -- to amend the public health services act regarding the 340B drug discount program. (opposition)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · second_quarter · 2A
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · first_quarter · 1A
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · second_quarter · Q2
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · second_quarter · Q2
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · second_quarter · Q2
Senate FY 2024 Appropriations bill (S.______, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act of 2023); funding for cybersecurity systems to prevent ransomware attacks, to protect patient health and medical information, and to further secure the personal data of patients and professional health staff.
Senate FY 2024 Appropriations bill (S.______, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act of 2023); funding for cybersecurity systems to prevent ransomware attacks, to protect patient health and medical information, and to further secure the personal data of patients and professional health staff.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · first_quarter · Q1
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · first_quarter · Q1
Senate FY 2024 Appropriations bill (S.______, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act of 2023); funding for cybersecurity systems to prevent ransomware attacks, to protect patient health and medical information, and to further secure the personal data of patients and professional health staff.
Senate FY 2024 Appropriations bill (S.______, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act of 2023); funding for cybersecurity systems to prevent ransomware attacks, to protect patient health and medical information, and to further secure the personal data of patients and professional health staff.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2023 · first_quarter · Q1
prescription drug issues, coverage and recognition for professional services
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · fourth_quarter · Q4
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · third_quarter · Q3
FDA policy and regulation of medical devices and drugs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF COVISUS CORPORATION) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · third_quarter · RR
FDA policies and regulations related to medical devices and drugs
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · fourth_quarter · Q4
Review and analysis of appropriations committee's community project funding
COVID provider relief; funding for patient care functions; 340(B) drug pricing; health provider workforce; accountable care organizations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · fourth_quarter · Q4
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · third_quarter · Q3
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · third_quarter · 3A
COVID provider relief; funding for patient care functions; 340(B) drug pricing; health provider workforce; accountable care organizations.
Review and analysis of appropriations committee's community project funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · third_quarter · Q3
COVID provider relief; funding for patient care functions; 340(B) drug pricing
Review and analysis of appropriations committee's community project funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · second_quarter · 2A
H. Rept. 117-403 Labor-HHS-Education Appropriations Bill, community project funding for convenient care clinic in North Aurora Illinois for Rush's Copley Medical center.
COVID provider relief; funding for patient care functions; 340(B) drug pricing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · second_quarter · 2A
COVID provider relief; funding for patient care functions
funding for convenient care clinic in North Aurora Illinois for Rush's Copely Medical center
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · first_quarter · RA
Health care -- COVID provider relief; funding for patient care functions
Health care -- COVID provider relief; funding for patient care functions
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · second_quarter · Q2
COVID provider relief; funding for patient care functions
funding for convenient care clinic in North Aurora Illinois for Rush's Copely Medical center
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · second_quarter · Q2
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · first_quarter · Q1
COVID provider relief; funding for patient care functions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2022 · first_quarter · Q1
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · fourth_quarter · Q4
COVID provider relief; funding for patient care functions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RUSH UNIVERSITY MEDICAL CENTER)) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · third_quarter · RR
Medicare reimbursement, COVID relief payments, healthcare staffing issues
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · fourth_quarter · Q4
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · third_quarter · Q3
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RAVENSAFE) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · third_quarter · 3T
recognition and utilization of mobile solar power systems
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP (ON BEHALF OF AYASS BIOSCIENCES) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · second_quarter · Q2
recognition of genomic sequencing processes
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RAVENSAFE) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · second_quarter · Q2
recognition and utilization of mobile solar power systems
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · second_quarter · Q2
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP (ON BEHALF OF RAVENSAFE) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · second_quarter · RR
support for renewable power generating equipment
support for renewable power generating equipment
THE LIVINGSTON GROUP (ON BEHALF OF AYASS BIOSCIENCES) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · second_quarter · RR
COVID-19 testing and surveillance issues
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2021 · first_quarter · Q1
coverage and recognition of professional services of clinical pharmacists, including, but not limited to, comprehensive medication management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · fourth_quarter · Q4
coverage for opioid addiction medicines and treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · fourth_quarter · Q4
awareness and potential utilization of solar power generators for disaster response and relief missions
awareness and potential utilization of solar power generators for military missions
exploration of government business opportunities
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), U.S. Agency for International Development (USAID)
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · fourth_quarter · Q4
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · third_quarter · Q3
awareness and potential utilization of solar power generators for disaster response and relief missions
exploration of government business opportunities
awareness and potential utilization of solar power generators for military missions
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), U.S. Agency for International Development (USAID)
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · third_quarter · Q3
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · third_quarter · Q3
coverage for opioid addiction medicines and treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · second_quarter · Q2
coverage for opioid addiction medicines and treatments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · second_quarter · Q2
awareness and potential utilization of solar power generators for military missions
exploration of government business opportunities
awareness and potential utilization of solar power generators for disaster response and relief missions
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), U.S. Agency for International Development (USAID)
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · second_quarter · Q2
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · first_quarter · Q1
coverage for opioid addiction medicines and treatments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · first_quarter · Q1
awareness and potential utilization of solar power generators for disaster response and relief missions
exploration of government business opportunities
awareness and potential utilization of solar power generators for military missions
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), U.S. Agency for International Development (USAID)
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2020 · first_quarter · Q1
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · fourth_quarter · Q4
coverage for opioid addiction medicines and treatments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · fourth_quarter · Q4
exploration of government business opportunities
awareness and potential utilization of solar power generators for military missions
awareness and potential utilization of solar power generators for disaster response and relief missions
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), U.S. Agency for International Development (USAID)
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · fourth_quarter · Q4
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · third_quarter · Q3
coverage for opioid addiction medicines and treatments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · third_quarter · Q3
exploration of government business opportunities
awareness and potential utilization of solar power generators for military missions
awareness and potential utilization of solar power generators for disaster response and relief missions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · third_quarter · Q3
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · second_quarter · Q2
coverage for opioid addiction medicines and treatments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · second_quarter · Q2
awareness and potential utilization of solar power generators for disaster response and relief missions
awareness and potential utilization of solar power generators for military missions
exploration of government business opportunities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · second_quarter · Q2
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · first_quarter · Q1
awareness and potential utilization of solar power generators for military missions
awareness and potential utilization of solar power generators for disaster response and relief missions
exploration of government business opportunities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF NJOY LLC) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · first_quarter · 1T
regulation of vaping products and devices
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF TITAN PHARMACEUTICALS) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · first_quarter · Q1
coverage for opioid addiction medicines and treatments
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2019 · first_quarter · Q1
coverage and recognition for comprehensive medication management
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NEXUS TECHNOLOGIES, INC via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2018 · fourth_quarter · Q4
cost effective power equipment for emergency uses
potential government uses of cost effective power equipment
recognition and utilization of cost effective power generation equipment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF CLINICAL PHARMACY via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2018 · fourth_quarter · Q4
Recognition and coverage for clinical pharmacy services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE LIVINGSTON GROUP, LLC (ON BEHALF OF NJOY LLC) via CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC
2018 · fourth_quarter · Q4
safety and use of NJOY products
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE